Thromboendarterectomy as Treatment in the Antiphospholipid Syndrome

Suzette W. Peng, MD; Jeanne P. Mitchell, MD

In This Article


Pulmonary thromboendarterectomy offers a potential cure for patients with chronic thromboembolic pulmonary hypertension that would otherwise suffer the complications of elevated pulmonary artery pressures, including right heart failure and death. In particular, early surgical referral of these patients is warranted when they meet the new ACCP guidelines. This case emphasizes that pulmonary thromboendarterectomy is feasible and has a favorable outcome in patients with APS and SLE.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.